Evidence suggests that PLOD1 overexpression may contribute to increased invasiveness and the mesenchymal subtype (MES) of glioblastoma, indicating that PLOD1 could serve as a potential treatment target for mesenchymal glioblastoma, and possibly for all types of glioblastoma (61). The gene discussed is PLOD1; the disease is glioblastoma.